The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

LEAD CHROMATE     dioxido-dioxo-chromium; lead(+2) cation

Synonyms: CCRIS 357, AG-H-10642, HSDB 1650, LS-53395, CTK3J2894, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Chrome Orange

 

High impact information on Chrome Orange

 

Chemical compound and disease context of Chrome Orange

 

Biological context of Chrome Orange

  • We found that aneuploid cells increased in a concentration- and time-dependent manner after chronic exposure to lead chromate [5].
  • Lead chromate-induced chromosome damage requires extracellular dissolution to liberate chromium ions but does not require particle internalization or intracellular dissolution [11].
  • We found that lead chromate was clastogenic in a concentration-dependent manner with 0.1, 0.5, and 1 microg/cm(2), while 5 and 10 microg/cm(2) caused complete cell cycle arrest [11].
  • The mechanism of metal-induced morphological transformation was likely not due to the specific base substitution mutations measured in ouabain resistance mutation assays, and for lead chromate, likely not due to this type of base substitution mutation or to frameshift mutations [12].
  • DNA damage induced by carcinogenic lead chromate particles in cultured mammalian cells [13].
 

Anatomical context of Chrome Orange

 

Associations of Chrome Orange with other chemical compounds

 

Gene context of Chrome Orange

 

Analytical, diagnostic and therapeutic context of Chrome Orange

References

  1. Tumorigenic activity of lead chromate. Furst, A., Schlauder, M., Sasmore, D.P. Cancer Res. (1976) [Pubmed]
  2. Cerebral arterial lesions resulting from inflammatory emboli. Foote, R.A., Reagan, T.J., Sandok, B.A. Stroke (1978) [Pubmed]
  3. Effects of anticoagulants in an animal model of septic cerebral embolization. Foote, R.A., Reagan, T.J., Sandok, B.A. Stroke (1978) [Pubmed]
  4. Cell-enhanced dissolution of carcinogenic lead chromate particles: the role of individual dissolution products in clastogenesis. Wise, J.P., Stearns, D.M., Wetterhahn, K.E., Patierno, S.R. Carcinogenesis (1994) [Pubmed]
  5. Chronic exposure to lead chromate causes centrosome abnormalities and aneuploidy in human lung cells. Holmes, A.L., Wise, S.S., Sandwick, S.J., Lingle, W.L., Negron, V.C., Thompson, W.D., Wise, J.P. Cancer Res. (2006) [Pubmed]
  6. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Patierno, S.R., Banh, D., Landolph, J.R. Cancer Res. (1988) [Pubmed]
  7. Three-dimensional microcomputed tomography of renal vasculature in rats. Garcia-Sanz, A., Rodriguez-Barbero, A., Bentley, M.D., Ritman, E.L., Romero, J.C. Hypertension (1998) [Pubmed]
  8. Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis. Singh, J., Pritchard, D.E., Carlisle, D.L., Mclean, J.A., Montaser, A., Orenstein, J.M., Patierno, S.R. Toxicol. Appl. Pharmacol. (1999) [Pubmed]
  9. Detection of the mutagenic activity of lead chromate using a battery of microbial tests. Nestmann, E.R., Matula, T.I., Douglas, G.R., Bora, K.C., Kowbel, D.J. Mutat. Res. (1979) [Pubmed]
  10. Acute bone marrow toxicity and pancytopenia following exposure to lead chromate, xylene, and ethylbenzene in a degloving injury. Erickson, T., Amed, V., Leibach, S.J., Bushnik, P., Saxon, A., Hryhorczuk, D.O., Knopse, W.H. Am. J. Hematol. (1994) [Pubmed]
  11. Lead chromate-induced chromosome damage requires extracellular dissolution to liberate chromium ions but does not require particle internalization or intracellular dissolution. Xie, H., Holmes, A.L., Wise, S.S., Gordon, N., Wise, J.P. Chem. Res. Toxicol. (2004) [Pubmed]
  12. Molecular mechanisms of transformation of C3H/10T1/2 C1 8 mouse embryo cells and diploid human fibroblasts by carcinogenic metal compounds. Landolph, J.R. Environ. Health Perspect. (1994) [Pubmed]
  13. DNA damage induced by carcinogenic lead chromate particles in cultured mammalian cells. Xu, J., Wise, J.P., Patierno, S.R. Mutat. Res. (1992) [Pubmed]
  14. Inhibition of lead chromate clastogenesis by ascorbate: relationship to particle dissolution and uptake. Wise, J.P., Orenstein, J.M., Patierno, S.R. Carcinogenesis (1993) [Pubmed]
  15. Effect of lead chromate on chromosome aberration, sister-chromatid exchange and DNA damage in mammalian cells in vitro. Douglas, G.R., Bell, R.D., Grant, C.E., Wytsma, J.M., Bora, K.C. Mutat. Res. (1980) [Pubmed]
  16. Clastogenicity of lead chromate particles in hamster and human cells. Wise, J.P., Leonard, J.C., Patierno, S.R. Mutat. Res. (1992) [Pubmed]
  17. Induction of apoptotic cell death by particulate lead chromate: differential effects of vitamins C and E on genotoxicity and survival. Blankenship, L.J., Carlisle, D.L., Wise, J.P., Orenstein, J.M., Dye, L.E., Patierno, S.R. Toxicol. Appl. Pharmacol. (1997) [Pubmed]
  18. XRCC1 protects against particulate chromate-induced chromosome damage and cytotoxicity in Chinese hamster ovary cells. Grlickova-Duzevik, E., Wise, S.S., Munroe, R.C., Thompson, W.D., Wise, J.P. Toxicol. Sci. (2006) [Pubmed]
  19. Biological monitoring of occupational exposure in the chromate pigment production industry. McAughey, J.J., Samuel, A.M., Baxter, P.J., Smith, N.J. Sci. Total Environ. (1988) [Pubmed]
  20. XRCC1 protects against particulate chromate-induced chromosome damage and cytotoxicity in Chinese hamster ovary cells. Grlickova-Duzevik, E., Wise, S.S., Munroe, R.C., Thompson, W.D., Wise, J.P. Toxicol. Sci. (2006) [Pubmed]
  21. Carcinogenic lead chromate induces DNA double-strand breaks in human lung cells. Xie, H., Wise, S.S., Holmes, A.L., Xu, B., Wakeman, T.P., Pelsue, S.C., Singh, N.P., Wise, J.P. Mutat. Res. (2005) [Pubmed]
  22. Induction of morphological transformation, anchorage-independent growth and plasminogen activators in non-tumorigenic human osteosarcoma cells by lead chromate. Sidhu, M.K., Fernandez, C., Khan, M.Y., Kumar, S. Anticancer Res. (1991) [Pubmed]
  23. Electron microscopy of golgi-stained material following lead chromate substitution. Ramon-Moliner, E., Ferrari, J. Brain Res. (1976) [Pubmed]
  24. Effects of chromium on lymphocyte subsets and immunoglobulins from normal population and exposed workers. Boscolo, P., Di Gioacchino, M., Bavazzano, P., White, M., Sabbioni, E. Life Sci. (1997) [Pubmed]
 
WikiGenes - Universities